NeuroSense Therapeutics Ltd. Ordinary Shares

NRSN XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

29M

Short interest (May 15)

1.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

5.75%

↓ 10.4%

Available Shares

600K

↓ 17.5%

Price Chart

Company Overview

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Company Info

Exchange: NASDAQ

CIK: 0001875091

Asset Type: CS

Market Data

Market Cap: $28,879,850

Employees: 16

Status: Active

Short Interest

Current Borrow Fee 5.75%

Range: 5.75% - 6.39%

Available Shares 600K

Range: 250K - 600K

Recent Changes

Fee Change: ↑ 4.9%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime